发明名称 1,2,3,4-TETRAHYDROQUINOXALINDIONE DERIVATIVE
摘要 A 1,2,3,4-tetrahydroquinoxalindione derivative represented by general formula (I) or a salt thereof, an NMDA-glycine receptor and/or AMPA receptor antagonist and a kainate neurocytotoxicity inhibitor each containing the same, and a medicinal composition comprising the above-mentioned compound and pharmaceutically acceptable carriers: wherein X represents N or CH; R represents imidazolyl or di(lower alkyl)amino; R<1> represents (1) halogeno, nitro, cyano, carboxy, amino, mono- or di(lower alkyl)amino, lower alkanoyl, lower alkylthio, lower alkylsulfinyl, lower alkylsulfonyl, or carbamoyl, (2) lower alkyl or lower alkoxy which may be substituted by halogeno, carboxy or aryl, or (3) phenyloxy which may be substituted by lower alkoxycarbonyl or carboxy; R<2> represents hydroxy, lower alkoxy, amino, or mono- or di(lower alkyl)amino; and A represents optionally substituted alkylene or -O-B- (B being lower alkylene); provided the case wherein R represents imidazolyl, R<1> represents cyano, A represents ethylene and R<2> represents hydroxy is excepted.
申请公布号 WO9610023(A1) 申请公布日期 1996.04.04
申请号 WO1995JP01922 申请日期 1995.09.25
申请人 YAMANOUCHI PHARMACEUTICAL CO., LTD.;SHISHIKURA, JUN-ICHI;INAMI, HIROSHI;SAKAMOTO, SHUICHI;TSUKAMOTO, SHIN-ICHI;SASAMATA, MASAO;OKADA, MASAMICHI;FUJII, MITSUO 发明人 SHISHIKURA, JUN-ICHI;INAMI, HIROSHI;SAKAMOTO, SHUICHI;TSUKAMOTO, SHIN-ICHI;SASAMATA, MASAO;OKADA, MASAMICHI;FUJII, MITSUO
分类号 C07D403/04;A61K31/498;A61K31/4985;A61P25/14;A61P25/28;C07D241/44;C07D471/04;C07D521/00;(IPC1-7):C07D403/04;A61K31/495 主分类号 C07D403/04
代理机构 代理人
主权项
地址